2 unchanged sentences
The repurchase program has no termination date and may be suspended or discontinued at any time.
−Removed: The following table summarizes the Company’s purchases of common stock under the share repurchase program during the fiscal quarter ended February 28, 2023:
+Added: The following table summarizes the Company’s purchases of common stock under the share repurchase program during the fiscal quarter ended May 31, 2023:
Period Total number of shares
4 unchanged sentences
purchased under the program (in thousands)
−Removed: December 1, 2022 - December 31, 2022 6,668 $ 122.90 — $ 354,085
−Removed: January 1, 2023 - January 31, 2023 58,709 $ 141.77 47,596 $ 347,417
−Removed: February 1, 2023 - February 28, 2023 63,800 $ 145.81 23,744 $ 344,083
+Added: March 1, 2023 - March 31, 2023 39,923 $ 132.71 39,084 $ 339,143
+Added: April 1, 2023 - April 30, 2023 845 $ 119.36 — $ 339,143
+Added: May 1, 2023 - May 31, 2023 84 $ 94.28 — $ 339,143
Total 40,852 $ 126.38 39,084
8 unchanged sentences
(incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 23, 2021).
+Added: 2.3 Share Purchase and Contribution Agreement, dated June 12, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 12, 2023).
3.1 Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on December 2, 2020).
3.2 Amended and Restated Bylaws of the Company, as amended (incorporated by reference to Exhibit 3.2 to the Company’s Annual Report on Form 10-K filed on January 28, 2022).
−Removed: 10.1 Put Option Agreement, dated as of March 29, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative, including the form of Stock Purchase and Contribution Agreement set forth as Schedule 3 thereto and the form of Sellers’ Note set forth as Schedule 7 thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
+Added: 10.1 Put Option Agreement, dated as of March 29, 2023, by and among Concentrix Corporation, OSYRIS S.à r.l., Marnix Lux SA, the other beneficiaries party thereto, and Sandrine Asseraf as the PoA Seller Representative, including the form of Sellers’ Note set forth as Schedule 7 thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
10.2 Investor Rights Agreement, dated as of March 29, 2023, by and among Concentrix Corporation and the initial stockholders party thereto (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
10.3 Commitment Letter, dated as of March 29, 2023, by and between Concentrix Corporation and JPMorgan Chase Bank, N.A (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
+Added: 10.4 Amendment and Restatement Agreement, dated as of April 21, 2023, by and among Concentrix Corporation, the lenders party thereto, JPMorgan Chase Bank, N.A., and Bank of America, N.A.
+Added: (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on April 26, 2023).
99.1 Voting and Support Agreement, dated March 29, 2023, by and among Concentrix Corporation, Marnix Lux SA, and certain stockholders of Concentrix Corporation (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K filed on March 31, 2023).
14 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: April 7, 2023 CONCENTRIX CORPORATION
+Added: July 7, 2023 CONCENTRIX CORPORATION
/s/ Christopher Caldwell
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.